Clinical Trial Update: Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing nivolumab to docetaxel in previously treated advanced/metastatic squamous cell non-small cell lung cancer has completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Squamous Cell Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-03-17